CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Double-blind, parallel arm, randomized controlled trial, in which non-lactating women with recent GDM who are between 6 to 36 months postpartum to be...
Phase 3
Toronto, Ontario, Canada
In type 1 diabetes (T1D), immune defense cells in the body attack and destroy insulin-producing beta cells leaving affected people with a li...
Phase 2, Phase 3
Toronto, British Columbia, Canada and 1 other location
The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and...
Phase 3
Oshawa, Ontario, Canada and 46 other locations
This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...
Phase 4
Stouffville, Ontario, Canada and 89 other locations
This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...
Phase 3
Toronto, Ontario, Canada and 175 other locations
This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...
Phase 3
Toronto, Ontario, Canada and 78 other locations
The purpose of the study is to evaluate the safety, tolerability, and efficacy of VX-264 in participants with type 1 diabetes (T1D)....
Phase 1, Phase 2
Toronto, Canada and 14 other locations
The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...
Phase 3
Toronto, Ontario, Canada and 652 other locations
double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...
Phase 2
Toronto, Ontario, Canada and 92 other locations
The aim of this study is to test the hypothesis that the effects on albuminuria of combination treatment with the endothelin receptor antagonist zibo...
Phase 2
Toronto, Ontario, Canada and 6 other locations
Clinical trials
Research sites
Resources
Legal